CIK: 0001615982 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,776,691 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $337,440 | 19.0% | $22.03 | +73.3% | COM | 03770N101 |
| — | METSERA INC | 3,750,662 | $196,272 | 11.0% | $27.22 | — | COM | 59267L107 |
| OCUL | OCULAR THERAPEUTIX INC | 13,161,462 | $153,857 | 8.7% | $4.80 | +149.2% | COM | 67576A100 |
| — | CIDARA THERAPEUTICS INC | 946,788 | $90,664 | 5.1% | $48.29 | — | COM NEW | 171757206 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,709 | $83,789 | 4.7% | $19.32 | -6.6% | COM | 92790C104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,728,985 | $81,959 | 4.6% | $8.91 | +55.1% | COM | 483497103 |
| ORKA | ORUKA THERAPEUTICS INC | 4,148,428 | $79,774 | 4.5% | $29.65 | -50.0% | COM | 687604108 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,596,885 | $79,163 | 4.5% | $7.60 | +38.4% | COM | 68622P109 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,226,331 | $66,043 | 3.7% | $18.38 | +9.7% | COM | 29337E102 |
| COGT | COGENT BIOSCIENCES INC | 4,000,000 | $57,440 | 3.2% | $8.47 | +39.9% | COM | 19240Q201 |
| CTMX | CYTOMX THERAPEUTICS INC | 15,561,500 | $49,641 | 2.8% | $1.68 | +34.3% | COM | 23284F105 |
| ABVX | ABIVAX SA | 576,729 | $48,964 | 2.8% | $11.63 | — | SPONSORED ADS | 00370M103 |
| SVRA | SAVARA INC | 12,681,043 | $45,271 | 2.5% | $2.80 | +5.6% | COM | 805111101 |
| SYRE | SPYRE THERAPEUTICS INC | 2,685,448 | $45,008 | 2.5% | $17.59 | -7.3% | COM NEW | 00773J202 |
| ERAS | ERASCA INC | 17,857,083 | $38,928 | 2.2% | $2.08 | -23.6% | COM | 29479A108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 960,803 | $37,808 | 2.1% | $17.70 | +44.4% | COM | 252828108 |
| ENGN | ENGENE HOLDINGS INC | 5,046,414 | $34,467 | 1.9% | $10.25 | -55.5% | COM | 29286M105 |
| MAZE | MAZE THERAPEUTICS INC | 1,230,769 | $31,914 | 1.8% | $16.88 | 0.0% | COM | 578784100 |
| JBIO | JADE BIOSCIENCES INC | 3,220,364 | $27,792 | 1.6% | $33.31 | -75.5% | COM NEW | 008064206 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $27,500 | 1.5% | $11.80 | -3.3% | COM | 26818M108 |
| VOR | VOR BIOPHARMA INC | 499,966 | $24,358 | 1.4% | $40.21 | 0.0% | COM NEW | 929033207 |
| UPB | UPSTREAM BIO INC | 1,169,298 | $21,994 | 1.2% | $22.33 | -30.4% | COM | 91678A107 |
| ZURA | ZURA BIO LTD | 4,631,216 | $20,053 | 1.1% | $2.58 | -30.4% | CLASS A ORD SHS | G9TY5A101 |
| — | ASTRIA THERAPEUTICS INC | 2,457,348 | $17,889 | 1.0% | $8.36 | — | COM | 04635X102 |
| PHVS | PHARVARIS N V | 674,599 | $16,831 | 0.9% | $15.96 | +38.9% | COM | N69605108 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,387,864 | $16,502 | 0.9% | $21.15 | -37.3% | COM | G2545C104 |
| SEPN | SEPTERNA INC | 610,808 | $11,489 | 0.6% | $8.80 | +49.2% | COM | 81734D104 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $8,183 | 0.5% | $21.29 | -65.6% | COM | 230031106 |
| SRZN | SURROZEN INC | 632,931 | $8,155 | 0.5% | $11.62 | -9.8% | COM NEW | 86889P208 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7,950 | 0.4% | $10.07 | +5.1% | CL A ORD SHS | G70077105 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $4,619 | 0.3% | $11.59 | -76.9% | COM | 04317A107 |
| TENX | TENAX THERAPEUTICS INC | 437,708 | $3,331 | 0.2% | $5.55 | +10.1% | COM NEW | 88032L605 |
| CASIF | CASI PHARMACEUTICALS INC | 987,259 | $1,639 | 0.1% | $6.09 | -70.7% | ORD SHS | G1933S101 |